Bryn E Mumma1, Scott D Casey2, Robert K Dang2, Michelle K Polen2, Jasmanpreet C Kaur2, John Rodrigo3, Daniel J Tancredi4, Robert A Narverud2, Ezra A Amsterdam5, Nam Tran3. 1. Department of Emergency Medicine, University of California, Davis, Sacramento, CA. Electronic address: bemumma@ucdavis.edu. 2. Department of Emergency Medicine, University of California, Davis, Sacramento, CA. 3. Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA. 4. Department of Pediatrics, University of California, Davis, Sacramento CA. 5. Division of Cardiovascular Medicine, Department of Internal Medicine, University of California, Davis, Sacramento CA.
Abstract
STUDY OBJECTIVE: Our objective is to describe the rates of diagnostic reclassification between conventional cardiac troponin I (cTnI) and high-sensitivity cardiac troponin T (hs-cTnT) and between combined and sex-specific hs-cTnT thresholds in adult emergency department (ED) patients in the United States. METHODS: We conducted a prospective, single-center, before-and-after, observational study of ED patients aged 18 years or older undergoing single or serial cardiac troponin testing in the ED for any reason before and after hs-cTnT implementation. Conventional cTnI and hs-cTnT results were obtained from a laboratory quality assurance database. Combined and sex-specific thresholds were the published 99th percentile upper reference limits for each assay. Cases underwent physician adjudication using the Fourth Universal Definition of Myocardial Infarction. Diagnostic reclassification occurred when a patient received a diagnosis of myocardial infarction or myocardial injury with one assay but not the other assay. Our primary outcome was diagnostic reclassification between the conventional cTnI and hs-cTnT assays. Diagnostic reclassification probabilities were assessed with sample proportions and 95% confidence intervals for binomial data. RESULTS: We studied 1,016 patients (506 men [50%]; median age 60 years [25th, 75th percentiles 49, 71]). Between the conventional cTnI and hs-cTnT assays, 6 patients (0.6%; 95% confidence interval 0.2% to 1.3%) underwent diagnostic reclassification regarding myocardial infarction (5/6 reclassified as no myocardial infarction) and 166 patients (16%; 95% confidence interval 14% to 19%) underwent diagnostic reclassification regarding myocardial injury (154/166 reclassified as having myocardial injury) by hs-cTnT. CONCLUSION: Compared with conventional cTnI, the hs-cTnT assay resulted in no clinically relevant change in myocardial infarction diagnoses but substantially more myocardial injury diagnoses.
STUDY OBJECTIVE: Our objective is to describe the rates of diagnostic reclassification between conventional cardiac troponin I (cTnI) and high-sensitivity cardiac troponin T (hs-cTnT) and between combined and sex-specific hs-cTnT thresholds in adult emergency department (ED) patients in the United States. METHODS: We conducted a prospective, single-center, before-and-after, observational study of ED patients aged 18 years or older undergoing single or serial cardiac troponin testing in the ED for any reason before and after hs-cTnT implementation. Conventional cTnI and hs-cTnT results were obtained from a laboratory quality assurance database. Combined and sex-specific thresholds were the published 99th percentile upper reference limits for each assay. Cases underwent physician adjudication using the Fourth Universal Definition of Myocardial Infarction. Diagnostic reclassification occurred when a patient received a diagnosis of myocardial infarction or myocardial injury with one assay but not the other assay. Our primary outcome was diagnostic reclassification between the conventional cTnI and hs-cTnT assays. Diagnostic reclassification probabilities were assessed with sample proportions and 95% confidence intervals for binomial data. RESULTS: We studied 1,016 patients (506 men [50%]; median age 60 years [25th, 75th percentiles 49, 71]). Between the conventional cTnI and hs-cTnT assays, 6 patients (0.6%; 95% confidence interval 0.2% to 1.3%) underwent diagnostic reclassification regarding myocardial infarction (5/6 reclassified as no myocardial infarction) and 166 patients (16%; 95% confidence interval 14% to 19%) underwent diagnostic reclassification regarding myocardial injury (154/166 reclassified as having myocardial injury) by hs-cTnT. CONCLUSION: Compared with conventional cTnI, the hs-cTnT assay resulted in no clinically relevant change in myocardial infarction diagnoses but substantially more myocardial injury diagnoses.
Authors: Kristian Thygesen; Johannes Mair; Evangelos Giannitsis; Christian Mueller; Bertil Lindahl; Stefan Blankenberg; Kurt Huber; Mario Plebani; Luigi M Biasucci; Marco Tubaro; Paul Collinson; Per Venge; Yonathan Hasin; Marcello Galvani; Wolfgang Koenig; Christian Hamm; Joseph S Alpert; Hugo Katus; Allan S Jaffe Journal: Eur Heart J Date: 2012-06-21 Impact factor: 29.983
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda Journal: J Biomed Inform Date: 2019-05-09 Impact factor: 6.317
Authors: Raffaele Bugiardini; Andrew T Yan; Raymond T Yan; David Fitchett; Anatoly Langer; Olivia Manfrini; Shaun G Goodman Journal: Eur Heart J Date: 2011-03-07 Impact factor: 29.983
Authors: Karen A Hicks; Kenneth W Mahaffey; Roxana Mehran; Steven E Nissen; Stephen D Wiviott; Billy Dunn; Scott D Solomon; John R Marler; John R Teerlink; Andrew Farb; David A Morrow; Shari L Targum; Cathy A Sila; Mary T Thanh Hai; Michael R Jaff; Hylton V Joffe; Donald E Cutlip; Akshay S Desai; Eldrin F Lewis; C Michael Gibson; Martin J Landray; A Michael Lincoff; Christopher J White; Steven S Brooks; Kenneth Rosenfield; Michael J Domanski; Alexandra J Lansky; John J V McMurray; James E Tcheng; Steven R Steinhubl; Paul Burton; Laura Mauri; Christopher M O'Connor; Marc A Pfeffer; H M James Hung; Norman L Stockbridge; Bernard R Chaitman; Robert J Temple Journal: Circulation Date: 2018-02-27 Impact factor: 29.690
Authors: Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Paul I Musey; Fernanda Bellolio; Suneel Upadhye; Anna Marie Chang; Deborah B Diercks; Michael Gottlieb; Erik P Hess; Michael C Kontos; Bryn E Mumma; Marc A Probst; John H Stahl; Jason P Stopyra; Jeffrey A Kline; Christopher R Carpenter Journal: Acad Emerg Med Date: 2021-07-06 Impact factor: 5.221